News from NORD

NORD Seeks Input Regarding Patient Protections and ACA


 

As the new administration and Congress consider replacing the Affordable Care Act with a new system, NORD is seeking input from patients and health care providers for its advocacy on behalf of rare disease patients. Patients or providers who have experiences or concerns to share regarding pre-existing conditions, annual or lifetime insurance caps, high-risk pools, or other topics may share their experiences with NORD.

Recommended Reading

Adolescents, boys, black children most likely to be hospitalized in SJS and TEN
MDedge Dermatology
Cardiofaciocutaneous Syndrome and the Dermatologist’s Contribution to Diagnosis
MDedge Dermatology
VIDEO: Despite toxicities, ibrutinib is beneficial for treatment-resistant graft-vs.-host disease
MDedge Dermatology
Join Others Around the World in Observing Rare Disease Day
MDedge Dermatology
AWaRDS Study Examines Services for Adults With Rare Disorders
MDedge Dermatology
New histopathologic marker may aid dermatomyositis diagnosis
MDedge Dermatology
Incidence of IBD is elevated in hidradenitis suppurativa patients
MDedge Dermatology
Hyperkeratotic Papules on the Medial Aspects of the Feet
MDedge Dermatology
IgG4-related disease can strike any organ system
MDedge Dermatology
Rituximab is dramatically effective in IgG4-related disease
MDedge Dermatology